skip to main content
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response
Material Type:
Artigo
Adicionar ao Meu Espaço

Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response

Baettig, Florence ; Vlajnic, Tatjana ; Vetter, Marcus ; Glatz, Katharina ; Hench, Jürgen ; Frank, Stephan ; Bihl, Michel ; Lopez, Roberto ; Dobbie, Michael ; Heinzelmann-Schwarz, Viola ; Montavon, Céline

Journal for immunotherapy of cancer, 2019-10, Vol.7 (1), p.281-281, Article 281 [Periódico revisado por pares]

England: BMJ Publishing Group Ltd

Texto completo disponível

2
Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8 + T cells in the tumor microenvironment
Material Type:
Artigo
Adicionar ao Meu Espaço

Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8 + T cells in the tumor microenvironment

Tada, Yasuko ; Togashi, Yosuke ; Kotani, Daisuke ; Kuwata, Takeshi ; Sato, Eichi ; Kawazoe, Akihito ; Doi, Toshihiko ; Wada, Hisashi ; Nishikawa, Hiroyoshi ; Shitara, Kohei

Journal for immunotherapy of cancer, 2018-10, Vol.6 (1), p.106-106, Article 106 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até

Buscando em bases de dados remotas. Favor aguardar.